Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by CD4 and CD8 T cells

Background. Previous studies have demonstrated that most marrow grafts from dog leukocyte antigen (DLA)-mismatched unrelated donors were rejected after 9.2 Gy total body irradiation (TBI), and that graft resistance could be overcome by infusing viable peripheral blood mononuclear cells (PBMCs) in addition to marrow. Methods. To investigate the donor cell populations that facilitate engraftment, we determined the minimal dose of PBMCs required to ensure stable engraftment. Nineteen dogs underwent transplantation with DLA-mismatched unrelated marrow and PBMCs in a dose de-escalation study. In subsequent studies, 12 dogs were given selected CD4 or CD8 cells in addition to marrow. Results. When 3×108 PBMC/kg were given in addition to a median of 4×108 marrow cells/kg, five of six animals engrafted. At a dose of 1×108 PBMC/kg, four of eight animals engrafted, and none of five dogs engrafted at a dose of 3×107 PBMC/kg. Accordingly, 12 dogs were given 9.2 Gy TBI, marrow grafts from DLA-mismatched unrelated dogs, and a median of 5.2×107 selected CD8 cells/kg or 10.4×107 selected CD4 cells/kg corresponding to the number of CD8 or CD4 cells contained in 3×108 PBMC/kg. Five of six dogs given CD8 cells and five of six dogs given CD4 cells engrafted. Conclusion. Results indicate that at least 3×108 unmodified PBMC/kg are needed for stable engraftment of DLA-mismatched unrelated marrow, and that both CD4 and CD8 cell subpopulations are capable of facilitating engraftment.

[1]  R. Pabst,et al.  Distribution of lymphocyte subsets and natural killer cells in the human body , 1992, The clinical investigator.

[2]  A. Hagenbeek,et al.  Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats. , 2002, Human gene therapy.

[3]  J. Thompson,et al.  Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes. , 2001, Blood.

[4]  Craig W. Reynolds,et al.  Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. , 2001, Blood.

[5]  M. Martelli,et al.  Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor. , 2000, Current opinion in immunology.

[6]  R. Storb,et al.  A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. , 1999, Blood.

[7]  G. Ehninger,et al.  Stable engraftment after megadose blood stem cell transplantation across the HLA barrier: the case for natural killer cells as graft-facilitating cells. , 1999, Transplantation.

[8]  M. Asaka,et al.  The role of accessory cells in allogeneic peripheral blood stem cell transplantation. , 1999, International journal of hematology.

[9]  A. Brownell,et al.  IL-2-activated murine newborn liver NK cells enhance engraftment of hematopoietic stem cells in MHC-mismatched recipients , 1998, Bone Marrow Transplantation.

[10]  P. Martin.  Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism. , 1996, Blood.

[11]  H. Deeg,et al.  Allogeneic transplants of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors , 1996 .

[12]  Simon C Watkins,et al.  Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. , 1994, Blood.

[13]  F. Appelbaum,et al.  Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow. , 1994, Bone marrow transplantation.

[14]  P. Martin,et al.  Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans , 1993, The Journal of experimental medicine.

[15]  F. Appelbaum,et al.  STUDIES OF THE USE OF L‐LEUCYL‐L‐LEUCINE METHYL ESTER IN CANINE ALLOGENEIC MARROW TRANSPLANTATION , 1993, Transplantation.

[16]  D. Danilenko,et al.  Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. , 1992, Tissue antigens.

[17]  S. Sambhara,et al.  Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. , 1991, Science.

[18]  R. Storb,et al.  Canine models of bone marrow transplantation. , 1990, Laboratory animal science.

[19]  K. Sullivan,et al.  Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. , 1989, The New England journal of medicine.

[20]  B. Dupont,et al.  Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. , 1987, Transplantation.

[21]  J. Thompson,et al.  T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect. , 1987, Transplantation proceedings.

[22]  H. Deeg,et al.  FAILURE OF ALLOGENEIC CANINE MARROW GRAFTS AFTER TOTAL‐BODY IRRADIATION: ALLOGENEIC “RESISTANCE” VERSUS TRANSFUSION‐INDUCED SENSITIZATION , 1986, Transplantation.

[23]  H. Deeg,et al.  Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors. , 1986, Blood.

[24]  B. Flynn,et al.  Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection. , 1985, Experimental hematology.

[25]  H. Deeg,et al.  Morphologic and phenotypic analysis of canine natural killer cells: evidence for T-cell lineage. , 1985, Cellular immunology.

[26]  H. Deeg,et al.  The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells. , 2008, Tissue antigens.

[27]  H. Deeg,et al.  Functional dichotomy of canine thoracic duct lymphocytes: proliferation in mixed leukocyte culture and unresponsiveness to plant lectins. , 1981, Journal of the Reticuloendothelial Society.

[28]  H. Deeg,et al.  Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes. , 1979, Blood.

[29]  R. Storb,et al.  MARROW GRAFTS BETWEEN DL‐A‐MATCHED CANINE LITTERMATES , 1973, Transplantation.

[30]  R. Storb,et al.  Marrow repopulating ability of peripheral blood cells compared to thoracic duct cells. , 1968, Blood.